Lundbeck To Market Teva's Azilect In Key Asian Countries
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Danish pharmaceutical company Lundbeck will sell Teva's Parkinson's disease drug Azilect in key Asian markets under a deal signed last week